About hemovent
hemovent is a company based in Aachen (Germany) founded in 2013 by Christof Lenz was acquired by MicroPort Orthopedics in October 2021. hemovent has raised $16.7 million across 3 funding rounds from investors including NRW.Bank, KfW and MicroPort Orthopedics. The company has 23 employees as of December 31, 2021. hemovent operates in a competitive market with competitors including Belluscura, Lungpacer, ALung, Breethe and Securisyn, among others.
- Headquarter Aachen, Germany
- Employees 23 as on 31 Dec, 2021
- Founders Christof Lenz
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Hemovent Gmbh
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$16.7 M (USD)
in 3 rounds
-
Latest Funding Round
$5.5 M (USD), Series B
Jul 07, 2020
-
Investors
NRW.Bank
& 5 more
-
Employee Count
23
as on Dec 31, 2021
-
Acquired by
MicroPort Orthopedics
(Oct 04, 2021)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
People of hemovent
Unlock access to complete
Funding Insights of hemovent
hemovent has successfully raised a total of $16.7M across 3 strategic funding rounds. The most recent funding activity was a Series B round of $5.5 million completed in July 2020. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in hemovent
hemovent has secured backing from 6 investors, including venture fund and institutional investors. Prominent investors backing the company include NRW.Bank, KfW and MicroPort Orthopedics.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
VC Firm funding companies in Europe
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked | |
|
TechVision Fonds is engaged in early-stage venture capital investments.
|
Locked | Locked | Locked |
Investor details for hemovent
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by hemovent
Investment portfolio details for hemovent
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - hemovent
Detailed financials for hemovent
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Hemovent Comparisons
Peer comparison for hemovent
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of hemovent
hemovent operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Belluscura, Lungpacer, ALung, Breethe and Securisyn, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Provider of medical devices for laparoscopic procedures
|
|
| Locked | Locked | Locked |
Neurostimulation-based pacer for diaphragm strength is developed.
|
|
| Locked | Locked | Locked |
Extracorporeal CO2 removal systems are developed to supplement mechanical ventilation.
|
|
| Locked | Locked | Locked |
Meditation programs are delivered through a mobile app by Breethe.
|
|
| Locked | Locked | Locked |
Endotracheal tube stabilization systems for ventilated patients are developed.
|
Detailed competitors of hemovent
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Hemovent
Complete news archive for hemovent
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about hemovent
hemovent was founded in 2013 and raised its 1st funding round 3 years after it was founded.
hemovent is headquartered in Aachen, Germany. It is registered at Aachen, North Rhine-westphalia, Germany.
Christof Lenz is the current CEO of hemovent. They have also founded this company.
hemovent is a funded company, having raised a total of $16.7M across 3 funding rounds to date.
As of Dec 31, 2021, the latest employee count at hemovent is 23.
Hemovent was founded in 2013 in Aachen, Germany, within the medical devices sector. The Mobybox system, based on the Bionique technology platform, is utilized for extracorporeal life support, CO2 removal, membrane oxygenation, and artificial blood circulation. Operations center on artificial lung functions and cardiopulmonary bypass systems, with applications in critical care environments across Europe.
hemovent's top competitors include Belluscura, Lungpacer and ALung.
hemovent has 6 investors. Key investors include NRW.Bank, KfW, MicroPort Orthopedics, MIG Capital, and WCTI Partners.